Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-07-31

Clinical Trial Update: Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis [NA]

View source ↗

Summary

A clinical trial evaluating the effect of midodrine on portal pressures in patients with cirrhosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midodrine (Midodrine)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Cirrhosis, End Stage Liver Disease | NA | Status: WITHDRAWN